Israel Englander In Med Pharmaceuticals Inc. Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding INM
# of Institutions
4Shares Held
790KCall Options Held
0Put Options Held
0-
Advisor Shares Investments LLC Bethesda, MD733KShares$2.32 Million0.03% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il56.7KShares$179,6310.0% of portfolio
-
Banque Cantonale Vaudoise125Shares$3960.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ27Shares$850.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $2.88M
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...